Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › K-ras mutations and anti-EGFr antibody therapy

K-ras mutations and anti-EGFr antibody therapy

US Patent 10030270 · Granted Jul 24, 2018

Estimated economic value: $464,817,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid biomarker and use thereof2025
Material and methods for treating or preventing HER-3 associated diseases2024
Material and methods for treating or preventing HER-3 associated diseases2024
Protein biomarker and uses thereof2024
Nucleic acid biomarker and use thereof2023
K-ras mutations and anti-EGFr antibody therapy2021
K-ras mutations and anti-EGFr antibody therapy2021
K-ras mutations and anti-EGFr antibody therapy2021
Material and methods for treating or preventing HER-3 associated diseases2018
Material and methods for treating or preventing HER-3 associated diseases2018
Material and methods for treating or preventing HER-3 associated diseases2017
Material and methods for treating or preventing HER-3 associated diseases2017